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Abstract
Background: The correlation between serum cholesterol level and the risk of developing 
atherosclerosis and metabolic syndrome has been well established in previous studies. Serum 
low-density lipoprotein (LDL-C) measurement is conducted using different methods which are 
generally divided into two groups, namely direct and indirect. Using indirect methods or calcu-
lations such as the Friedewald or Iranian formula for measuring LDL, particularly in developing 
countries, is quite common. The present study has stepped in to compare the robustness of the 
extant formulas in prognosticating and determining the incidence of metabolic syndrome. Ma-
terials and Methods: In this cross-sectional study, the target population was the community of 
Fasa cohort study. According to the views of the statistical advisor, 9530 people were includ-
ed in the study and clinical laboratory examinations were done for each person. Their serum 
LDL level was measured using the existing formulas. Then, the results of the serum LDL level 
that was computed with different formulas, were compared with both the status of metabolic 
syndrome and laboratory tests of individuals. Results: The Iranian formula has the highest 
area under curve, the sensitivity of 0.73, and specificity of 0.77, higher positive and negative 
predictive values among other formulas. In Friedewald formula, for example, sensitivity and 
specificity equal 0.28 and 0.80, respectively. After further analysis, two new models proposed 
for predicting metabolic syndrome. The results revealed that these two models even outperform 
the Iranian formula. Conclusion: The Iranian formula for plasma LDL calculation has higher 
precision and application for predicting and measuring the metabolic syndrome in the Iranian 
population due to its considerable features. It is required to develop a new formula for each 
population and even for each sex, if possible.[GMJ.2020;9:e1607] DOI:10.31661/gmj.v9i0.1607
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Introduction
The correlation between serum cholesterol and the risk of developing atherosclerosis 
has been well established in previous research, 
such as Framingham study [1, 2]. In human 
blood, much of the circulating cholesterol is 
carried by low-density lipoprotein (LDL); 
therefore, total cholesterol concentration is a 
good indicator of LDL cholesterol (LDL-C) 
level. According to the latest NCEP guide-
lines for the adult treatment panel, the diag-
nosis and treatment of hypercholesterolemia 
are entirely based on the measurement of total 
cholesterol and LDL-C levels [3]. Treatment 
aims to diminish LDL-C below the target val-
ues [2]. The LDL-C is a reliable marker for 
prognosticating the coronary heart disease. To 
date, various studies have asserted the strong 
correlation between increased LDL-C and 
coronary heart disease [4-6]. Serum LDL-C 
measurement is conducted using different 
methods which are generally divided into two 
groups, namely direct and indirect. There are 
various direct methods to this end; however, 
the reference and direct measurement of LDL 
is performed using a combination of ultracen-
trifugation-polianion precipitation, which is 
neither easily available nor feasible in routine 
labs. The new method for direct measurement 
of LDL is homogenous assay which is highly 
accurate, albeit considerably costly [7]. Con-
sidering the limitations mentioned above, us-
ing indirect methods or calculations such as 
the Friedewald formula for measuring LDL, 
particularly in developing countries, is quite 
common. However, evidence and some re-
ports have revealed inconsistencies between 
the results of the homogeneous methods and 
those of the Friedewald formula, and this has 
led to a concerted effort to reach a more pre-
cise formula [8]. One of these attempts was 
made by Ahmadi et al. [9] who developed an 
Iranian formula for calculating LDL. Many 
other researchers, including Anandaraja [2], 
Vujovic [6], and Chen [10], also put forth 
new formulas for measuring LDL. Hitherto, 
no study, whether in Iran or abroad, has com-
pared the robustness of all these formulas and 
their precision in predicting the status of met-
abolic syndrome in patients, hence the present 
study has stepped in to compare the robust-
ness of the extant formulas in prognosticating 
and determining the incidence of metabolic 
syndrome.
Materials and Methods
In Fasa Cohort Study, a part of the Persian 
cohort study, more than 10,000 people with 
age range of 35 to 70 years were investigat-
ed. The demographics, socioeconomic status, 
nutritional status, medical history, body com-
position, electrocardiogram test, and clinical 
laboratory examinations, were collected from 
each person. Also, a biobank of urine, blood, 
hair, and nail samples was compiled for fur-
ther research. All information is recorded on-
line for ease of access [11].
Exclusion and inclusion criteria
All individuals with complete information 
were included in the study.
Research ethical
Research committee registration code: IR.
FUMS.REC.1397.096 In this cross-sectional 
study, the target population was the commu-
nity of Fasa cohort study. According to the 
views of the statistical advisor, 9530 people 
were included in the study, and their LDL lev-
el was measured using the following formu-
las:
Methods for measurement of LDL-C
1. Fried Ewald’s formula [12]:
a. LDL-C (mg/dL) = TC-HDL-(TG/5)
b. LDL-C (mmol/L) = TC-HDL-(TG/2.2)2
2. Ananda raja’s formula (Indian) [2]:
LDL-C (mg/dL) = (0.9*TC)-0.9*(TG/5)-28
3. Modified [6]:
LDL-C (mmol/L) = TC-(TG/3)-HDL
4. Modified Fried Ewald’s formula [10]:
LDL-C (mg/dL) = Non-HDL*0.9-(TG*0.1)
(Non-HDL=TC–HDL)
5. A new accurate, simple formula [13]:
LDL = ¾ (TC - HDL)
6. Iranian formula [9]:
a. LDL (mg/dL) = (TC/1.19)+(TG/1.9)-(H-
DL/1.1)-38
b. LDL (mmol/L) = (TC/1.19)+(TG/0.81)-(H-
DL/1.1)-0.98
In these formulas, TC, TG, and HDL represent 
total cholesterol, high-density lipoprotein, and 
triglycerides, respectively. 
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The metabolic syndrome is assumed to be 
present provided that three or more of the fol-
lowing parameters are met [14]:
1. The waistline is more than 40 inches (102 
centimeters) for men and more than 35 inches 
(89 centimeters) for women 
2. HDL is less than 40 mg/dL in men and less 
than 50 mg/dL in women
3 Triglyceride level is 150 mg/dL or higher
4. Blood pressure is 130/85 mm Hg or higher
5. Fasting blood sugar is 100 mg/dL or higher
Then, the results of the LDL level computed 
with different formulas were compared with 
both the status of metabolic syndrome and 
laboratory tests of individuals. After review-
ing the results, more analysis was carried out 
to find more robust formulas..
Data analysis
Descriptive statistics were reported as number 
(percentage) or mean± SD. Independent T-test 
was used to compare quantitative variables 
between two groups and logistic regression 
analysis performed for modeling associated 
factors with metabolic syndrome. Moreover, 
ROC curve analysis was used to obtain the 
area under the curve, sensitivity, and specific-
ity of different LDL formulas. All the statisti-
cal analyses performed in SPSS (IBM Co., Ar-
monk, NY, USA) 18.0 and MedCalc (Medcalc 
software, Ostend, Belgium) 14.0 software and 
P<0.05 considered as statistically significant.
Results
Table-1 depicts the comparison of the vari-
ables under scrutiny between people with and 
without metabolic syndrome. The results con-
firm that except for HCT, SGOT, and RBC, 
other variables have significant differences 
between the two groups. Table-2 shows the 
LDL numbers calculated by different methods 
among people with metabolic syndrome and 
non-metabolic syndrome. Figure-1 exhibits 
the prevalence of the disease in each quartile 
of the formulas. For example, in the fourth 
quartile of the Iranian formula, 54.5% of peo-
ple are afflicted with metabolic syndrome. 
The results of the Receiver Operating Charac-
teristic (ROC) curve analysis are presented in 
Table-3. The columns represent the area under 
the curve (AUC), sensitivity, specificity, pos-
itive and negative predictive values, and opti-
mum cut-off point, respectively. As observed, 
the Iranian formula has the highest area under 
the curve, sensitivity, and specificity. Figure-2 
plots the formulas’ AUC. After further analy-
sis, the results of two new models proposed 
for predicting metabolic syndrome are pre-
sented in Table-4. The results revealed that 
Figure 1. Proportion of metabolic syndrome among different quartile of each formula
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these two models even outperform the Iranian 
formula. The first model uses three variables, 
and the second model employs four variables. 
The AUC, sensitivity, and specificity of the 
models are reported at the end of the table, 
which portrays the superiority of the proposed 
models to all existing formulas. In the second 
model, the sex is also considered (in computa-
tions, one and zero stand for female and male, 
respectively).
Table 1. Comparison of Characteristics between Patients With IDF1 Metabolic Syndrome and Healthy 
Group
Characteristic
IDF metabolic syndrome P-value
No (n=7322) Yes (n=2186) <0.001
Age 48.21± 9.42 51.40± 9.23 <0.001
BMI 24.80± 4.62 28.66± 4.29 <0.001
Waist circumference 90.86± 11.33 101.22± 9.63 <0.001
Hip circumference 98.35± 8.68 103.61± 8.52 <0.001
Wrist circumference 16.60± 1.29 17.10± 1.43 <0.001
WBC 6.39± 1.73 6.76± 1.75 <0.001
RBC 4.96± 0.57 4.97± 0.57 0.51
HGB 14.74± 1.72 14.58± 1.67 <0.001
HCT 42.04± 4.43 41.85± 4.34 0.07
MCV 85.15± 7.84 84.57± 7.41 0.002
MCH 29.89± 3.30 29.48± 3.14 <0.001
MCHC 35.05± 1.24 34.81± 1.30 <0.001
PLT 270.48± 71.27 291.80± 74.43 <0.001
LY 42.40± 10.21 42.98± 9.93 0.02
MO 3.21± 1.36 3.31± 1.42 0.004
GR 54.37± 10.85 53.71± 10.62 0.01
GLOC 88.18± 20.20 109.02± 45.98 <0.001
BUN 13.03± 4.00 12.74± 3.86 0.003
creatinine 0.98± 0.20 0.97± 0.18 0.02
TG 113.02± 61.98 196.43± 106.69 <0.001
Cholesterol 182.63± 37.38 196.41± 42.45 <0.001
SGOT 22.47± 8.20 22.71± 8.93 0.25
SGPT 22.52± 13.74 25.91± 15.23 <0.001
ALP 206.49± 70.26 223.05± 66.37 <0.001
HDL 53.37± 16.35 45.05± 13.12 <0.001
GGT 21.52± 20.54 26.96± 20.91 <0.001
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Model 2: pi =
e−4.67+0.053∗age+0.016∗TG−0.057∗HDL+1.97∗female gender
1+e−4.67+0.053∗age+0.016∗TG−0.057∗HDL+1.97∗female gender
 
 
Model 1: pi =
e−1.99+0.003∗total cholestrol+0.013∗TG−0.035∗HDL
1+e−1.99+0.003∗total cholestrol+0.013∗TG−0.035∗HDL
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Table 2. Comparison of Obtained Scores in Each Formula between Cases with and without Metabolic 
Syndrome
P-value
IDF Metabolic Syndrome
LDL Formula
YesNo
<0.001112.07± 35.67106.65± 31.79Fried Ewald’s LDL
0.001113.41± 35.42116.03± 31.17Ananda raja’s LDL
<0.00185.89± 39.3891.59± 31.76Modified LDL
<0.001116.58± 32.60105.03± 29.68Modified Fried Ewald’s LDL
<0.001113.52± 30.1496.94± 26.72New accurate LDL
<0.001251.16± 109.63161.93± 71.35Iranian LDL
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Discussion
According to the results of the study, the Ira-
nian formula for plasma LDL calculation has 
higher precision and application for predict-
ing and measuring the metabolic syndrome in 
the Iranian population due to its considerable 
features, i.e., sensitivity of 0.73, specificity of 
0.77, higher positive and negative predictive 
values, and area under the curve. In Friede-
wald formula, for example, sensitivity and 
specificity equal 0.28 and 0.80, respectively. 
In Table-4 that illustrates the first model, it can 
be observed that this model is more precise 
than the previous methods due to its sensitivi-
ty (0.76), specificity (0.77), and area under the 
curve (0.83). The second model, which also 
considers sex, is more robust than both the first 
model and other existing methods. According 
to the results presented in Table-1, metabolic 
syndrome has a significant correlation with 
most demographic indicators and laboratory 
data. The results exhibited in Figure-1 reveal 
that in Fried, Modified Fried, New Accurate, 
and Iranian formulas, more people with meta-
bolic syndrome are present in the fourth quar-
tile of the calculated LDL. Contrariwise, in 
Anandaraja and Modified formulas, the first 
quartile encompasses more afflicted people. 
Anandaraja et al. believed that the Friede-
wald formula shows variable percentages of 
agreement with the direct method in different 
geographic regions; therefore, they developed 
a new formula with a better agreement with 
direct measurement of LDL for Indian popu-
lation compared with the Friedewald formula. 
Moreover, the LDL calculation by this meth-
od only requires triglyceride measurement, 
which is more cost-effective than the Friede-
wald formula [2]. De Cordova and colleagues 
in their study on a cohort of Brazil population 
found that the Friedewald formula fails to have 
a good agreement with direct measurement 
method for people with high or low triglycer-
ide; thus, they proposed a formula that can be 
used to measure serum LDL in a wider range 
of populations with better agreement [13]. In 
their study, Vujovic et al. used Friedewald 
and Anandaraja formulas to calculate LDL of 
a Serb population and compared the results 
with direct LDL measurement. Then, they de-
veloped a new formula using the regression 
method to calculate LDL of the Serb popula-
tion; they asserted that the proposed method 
Table 3. Results of ROC Analysis for Different Formulas
LDL formula AUC Sensitivity Specificity PPV NPV Cut of point
Iranian formula 0.80 (0.79-0.81) 0.73 (0.71-0.75) 0.77 (0.76-0.78) 0.49 0.91 196.35
New accurate 0.67 (0.66-0.68) 0.65 (0.63-0.67) 0.60 (0.59-0.61) 0.33 0.85 102
Modified. Fried 0.61 (0.60-0.62) 0.70 (0.68-0.72) 0.46 (0.45-0.47) 0.28 0.84 100.5
Fried 0.55 (0.54-0.56) 0.28 (0.26-0.30) 0.80 (0.79-0.81) 0.29 0.79 131.8
Modified 0.54 (0.53-0.55) 0.23 (0.22-0.25) 0.85 (0.84-0.86) 0.31 0.79 60.3
Ananda 0.52 (0.51-0.53) 0.15 (0.13-0.17) 0.91 (0.90-0.92) 0.33 0.78 77.3
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Figure 2. ROC curve of LDL formulas
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Table 4. Results of Proposed Models to Predict Metabolic Syndrome
Model 1 Model 2
Variable OR (95% CI) P-value Variable OR (95% CI) P-value
Total cholesterol 1.003 (1.002-1.005) <0.001 age 1.05 (1.05-1.06) <0.001
HDL 0.97 (0.96-0.97) <0.001 HDL 0.945 (0.94-0.95) <0.001
TG 1.013 (1.012-1.014) <0.001 TG 1.016 (1.015-1.017) <0.001
Female gender 7.16 (6.20-8.26) <0.001
AUC=0.83 (0.82-0.84), Sen=0.76, spec=0.77 AUC=0.87 (0.86-0.88), Sen=0.81, spec=0.78
is more accurate than the two formulas used 
in the study [6]. Chen et al. (2010) offered 
and tested a simple formula for calculating 
LDL. They compared their formula with Frie-
dewald equation in terms of agreement with 
the direct method of measuring LDL and ob-
served that the results of their new formula are 
much closer to the results of the direct method 
compared with the Friedewald formula. Addi-
tionally, their proposed formula dramatically 
lessens the interference generated by hyper-
triglyceridemia in computing LDL [10]. In 
another study, the Friedewald, Vujovic, Chen, 
and Anandaraja formulas were compared with 
eight direct methods of LDL computation. 
The findings indicated that for fasting samples 
in subjects with normal triglyceride (TG<200 
mg/dL); the Friedewald formula has the best 
performance for measuring LDL. It should be 
noted that the precision of the Friedewald for-
mula is variable depending on the HDL mea-
surement method. None of the four formulas 
had good performance for samples with high 
triglyceride [15]. Likewise, Ahmadi et al. 
concluded that the Friedewald formula fails to 
be effective for people with high triglyceride 
level [9]. Mora et al. used the direct method 
and Friedewald formula to predict CVD from 
serum LDL-C in subjects with TG ≤ 400 mg/
dL. The results showed that both methods are 
reliable for fasting samples [16]. In a study by 
Schectman et al., it was shown that despite 
this widespread perception that the indirect 
formula, encompassing TC, TG, and HDL, 
may cause an error in the calculation of LDL 
or give an unrealistic estimation as a result of 
a change in a parameter and deviation from 
the normal range, the indirect method is not 
significantly different from the direct method 
[17].
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Conclusion
Based on the results of the study, the Irani-
an formula for plasma LDL level calculation 
has higher precision and application and is 
the best one for predicting and measuring the 
metabolic syndrome in the Iranian popula-
tion. As observed in the relevant studies, it is 
required to develop a new formula for each 
population and even for each sex, if possible, 
relying upon sufficient studies to reach the 
minimum error and maximum accuracy and 
performance.
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